Join
Live feed
·
PRReleasevia Quantisnow
DBV Technologies S.A. logo

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

ByQuantisnow·Wall Street's wire, on your screen.
DBVT· DBV Technologies S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DBVT (DBV Technologies S.A.) and more on Quantisnow.